Pipeline

Pipeline

UBX-067

CDK2 Degraducer

Solid tumors

STEP IN PROGRESS

Research

Preclinical

Ph1

Ph2

Ph3

NDA

Ownership

UBX-053

BTK Degraducer

B-cell malignancies

STEP IN PROGRESS

Research

Preclinical

Ph1

Ph2

Ph3

NDA

Ownership

UBX-053

Development of B-cell disease therapeutics through BTK degradation

Novel E3 ligase binders & platform technologies

Novel CRBN binder #2

STEP IN PROGRESS

Research

Evaluation

Development

Ownership

Novel CRBN binder #1

STEP IN PROGRESS

Research

Evaluation

Development

Ownership

We are conducting research to discover novel E3 binders with differentiated profiles, and results are being produced step by step.